Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In-vivo transmission model in semi-immune adult males
PACTR202312585218142Phase 1Not yet recruiting
- Sponsor
- Ifakara Health Institute
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of piperaquine and doxycycline, sponsored by Ifakara Health Institute. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
piperaquinedoxycycline
Beyond the preview
Go deeper on PACTR202312585218142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202312585218142.